Article Per Year (5 Year)
p-Index From 2021 - 2026
0
P-Index
This Author published in this journals
All Journal Conferences of Medical Sciences Dies Natalis
Zen Ahmad
Fakultas Kedokteran Universitas Sriwijaya Palembang
Biochemistry, Genetics & Molecular Biology Dentistry Health Professions Immunology & microbiology Medicine & Pharmacology Neuroscience Nursing Public Health

Published : 2 Documents Claim Missing Document
Claim Missing Document
Check
Articles

Found 2 Documents
Search

 1 
Pemilihan Bronkodilator Pada Penyakit Paru Obstruktif Kroni Zen Ahmad
Conferences of Medical Sciences Dies Natalis Vol. 1 No. 1 (2019): Conferences of Medical Sciences Dies Natalis Faculty of Medicine Universitas Sr
Publisher : Fakultas Kedokteran Universitas Sriwijaya

Show Abstract | Download Original | Original Source | Check in Google Scholar | Full PDF (1251.705 KB)

Abstract

Chronic obstructive pulmonary disease (COPD) is a disease that is often found, can be prevented and treated. It characterized by symptoms of persistent respiration and obstruction of airflow, associated with airway disorders and/or alveoli due to exposure to significant harmful particles or gases. COPD currently causes the world's fourth death and is projected to be third in 2020. In 2012, COPD has caused 3 million deaths (6% of all deaths) and will contribute 4.5 million deaths by 2030. COPD requires high costs especially in exacerbation conditions that require hospital treatment.Exposure to cigarette smoke or harmful agents will cause stimulation of macrophages and airway epithelium. Stimulation of macrophages will stimulate inflammatory processes and the underlying cascade such as protease formation and increased oxidative stress. One treatment of COPD is through pharmacological therapy approaches using a bronchodilator which aims to overcome airflow limitation with or without the addition of corticosteroids, mucolytics, antioxidants, and other drugs. The choice of bronchodilators in COPD patients is very individual. The selection must pay attention to the degree of the complaint, the magnitude of the risk of exacerbation, side effects, drug availability, costs, the presence of comorbid diseases and device inhalers.
COVID 19: REALS AND CHALLENGES AGAINST DOCTORS Zen Ahmad
Conferences of Medical Sciences Dies Natalis Vol. 2 No. 1 (2020): Conference of Medical Sciences Dies Natalis Faculty of Medicine Universitas Sri
Publisher : Fakultas Kedokteran Universitas Sriwijaya

Show Abstract | Download Original | Original Source | Check in Google Scholar | Full PDF (1686.92 KB)

Abstract

Corona Virus Disease (Covid-19) is a contagious disease caused by Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) which was discovered in December 2019 in China. This disease can cause clinical manifestations in the airway, lung and systemic. The World Health Organization (WHO) representative of China reported a pneumonia case with unknown etiology in Wuhan City, Hubei Province, China on December 31, 2019. The cause was identified as a new type of coronavirus on January 7, 2020 with an estimated source of the virus from traditional markets (seafood market). ) Wuhan city
Co-Authors